Carolina Public Health magazine - Solving North Carolina's Public Health Challenges (Fall, 2013)

CONTACT INFORMATION

Visit our communications and marketing team page.
Contact sphcomm@unc.edu with any media inquiries or general questions.

Communications and Marketing Office
125 Rosenau Hall
CB #7400
135 Dauer Drive
Chapel Hill, NC 27599-7400

Paxlovid and molnupiravir substantially reduced hospitalization and death from Omicron variants

READ

September 21, 2023
New research conducted by the UNC Gillings School of Global Public Health and the Cleveland Clinic shows that ritonavir-boosted nirmatrelvir (Paxlovid) and molnupiravir (Lagevrio) substantially reduced COVID-19 hospitalization and death among high-risk patients, even against the most recent Omicron subvariants BQ.1.1 and XBB.1.5.

Improving access to public toilets can reduce health hazards in cities 

UNC Gillings School to host new CDC center for outbreak forecasting, response

Lusajo Kajula, Fulbright Scholar-in-Residence, encourages Gillings students to ‘think globally’

UNC Gillings scientist recognized by Time100 Next

See All Latest News

Carolina Public Health magazine - Solving North Carolina's Public Health Challenges (Fall, 2013)

Table of Contents

Paxlovid and molnupiravir substantially reduced hospitalization and death from Omicron variants

Information for: